DRKS00022457进行中（未招募）不适用
on-interventional Study (NIS) to provide Information about Infliximab-Pen for Subcutaneous Infliximab Application (product: Remsima® 120 mg)
Celltrion Healthcare Deutschland GmbH0 个研究点目标入组 81 人开始时间: 2020年7月17日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 81
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Signed informed consent (data protection)
- •- Male and female outpatient aged =18 years with the further need of treatment of rheumatoid arthritis (RA), ankylosing spondylitis (AS) or
- •psoriatic arthritis (PsA)
- •- Experience with Remsima®-Pen for at least 3 self-injections at first or later re-visit of patient after hand-over of the Remsima®-Pen at the physician site
排除标准
- •- Patient <18 years (children and adolescents)
- •- Patient who exhibit contraindications according to SPC (Summary of Product Characteristics) for Remsima® 120 mg or hypersensitivity to any of the ingredients of Remsima® 120 mg is known and therefore treatment with Remsima® 120 mg is not indicated
研究者
相似试验
已完成
不适用
A clinical study for the development of Magnetic Resonance Imaging (MRI) of the testis in healthy adult subjectsMale infertilityJPRN-UMIN000042373ational Cancer Center10
招募中
1 期
An Interventional and Translational Study investigating Sotorasib in Previously Treated Locally Advanced or Metastatic NSCLC Subjects With Mutated KRAS p.G12C (CODEBREAK)locally-advanced and unresectable or metastatic NSCLC with KRAS G12CMedDRA version: 21.1Level: PTClassification code: 10061873Term: Non-small cell lung cancer Class: 100000004864MedDRA version: 25.1Level: LLTClassification code: 10069759Term: KRAS mutation Class: 10018065CTIS2024-510837-16-00Institut Gustave Roussy40
进行中（未招募）
1 期
An Interventional and Translational Study investigating Sotorasib in Previously Treated Locally Advanced or Metastatic non-small-cell lung cancerocally-advanced and unresectable or metastatic non-small-cell lung cancer with KRAS G12C mutationEUCTR2021-006958-31-FRGustave Roussy40
尚未招募
Unknown
A study to assess the role of CognitiveBotics software (Artificial Intelligence based software) in the management of Autism Spectrum Disorder.CTRI/2023/06/054257CognitiveBotics Technologies Private Limited
招募中
不适用
Registration study on InterventioIschemic heart diseaseJPRN-UMIN000015397KICS10,000